Karolina F Larsson, Annabelle Forsmark, Henrik Fagman, Maja Drakenberg Danese, Maria Kaire, Matilda Liljedahl, Christoffer Vannas
{"title":"一名大量预处理的转移性乳腺癌患者对alpelisib的特殊反应,该患者携带SOLAR-1以外的PIK3CA突变:一个病例报告。","authors":"Karolina F Larsson, Annabelle Forsmark, Henrik Fagman, Maja Drakenberg Danese, Maria Kaire, Matilda Liljedahl, Christoffer Vannas","doi":"10.2340/1651-226X.2026.46486","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":7110,"journal":{"name":"Acta Oncologica","volume":"65 ","pages":"776-780"},"PeriodicalIF":2.7000,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13615411/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exceptional response to alpelisib in a heavily pretreated patient with metastatic breast cancer carrying a PIK3CA mutation outside SOLAR-1 eligible mutations: a case report.\",\"authors\":\"Karolina F Larsson, Annabelle Forsmark, Henrik Fagman, Maja Drakenberg Danese, Maria Kaire, Matilda Liljedahl, Christoffer Vannas\",\"doi\":\"10.2340/1651-226X.2026.46486\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":7110,\"journal\":{\"name\":\"Acta Oncologica\",\"volume\":\"65 \",\"pages\":\"776-780\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2026-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13615411/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Oncologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2340/1651-226X.2026.46486\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Oncologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2340/1651-226X.2026.46486","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
Exceptional response to alpelisib in a heavily pretreated patient with metastatic breast cancer carrying a PIK3CA mutation outside SOLAR-1 eligible mutations: a case report.
期刊介绍:
Acta Oncologica is a journal for the clinical oncologist and accepts articles within all fields of clinical cancer research. Articles on tumour pathology, experimental oncology, radiobiology, cancer epidemiology and medical radio physics are also welcome, especially if they have a clinical aim or interest. Scientific articles on cancer nursing and psychological or social aspects of cancer are also welcomed. Extensive material may be published as Supplements, for which special conditions apply.